Generics 51

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Hyoscine butylbromide manufacturers

51 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

51 products found

hyoscine butylbromide

Tablets 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120
This globally competitive organization specializes in formulating a wide range of medications and exports to over 40 countries. Their state-of-the-art manufacturing facilities are strategically located across three cities, adhering to stringent regulatory standards like those set by the EU, UK, and UNICEF. They produce diverse dosage forms including tablets, capsules, creams, ointments, gels, and sterile formulations such as lyophilized products and prefilled syringes. Key therapy areas include complex generics, orphan drugs, and treatments for neglected tropical diseases. The company holds GMP certifications and possesses product patents, emphasizing their commitment to quality and innovation. They actively participate in global initiatives, providing emergency stockpiles for coronavirus treatments and partnering with organizations to address the healthcare needs of Palestinian refugees.

Manufacturer usually replies in 7 days

hyoscine butylbromide

Injection 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21177
This company, established in the 1980s, operates within South Asia, specializing in the manufacture and supply of pharmaceutical products. Their offerings include tablets, capsules, eye, ear, and nasal drops, as well as oral and injectable suspensions. The company holds EU and US GMP approvals, signifying adherence to high manufacturing standards. Their production lines cater to a diverse range of therapeutic areas, with a focus on infectious diseases, pain management, and ophthalmology. The company boasts a sizable workforce and has a global reach, catering to markets across the world. They are recognized for their commitment to quality, utilizing high-grade chemicals and advanced machinery for production. The company emphasizes its track record in providing quality pharmaceutical products, underscoring its experience in the industry.

Manufacturer usually replies in 5 days

hyoscine butylbromide

Tablets 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21177
This company, established in the 1980s, operates within South Asia, specializing in the manufacture and supply of pharmaceutical products. Their offerings include tablets, capsules, eye, ear, and nasal drops, as well as oral and injectable suspensions. The company holds EU and US GMP approvals, signifying adherence to high manufacturing standards. Their production lines cater to a diverse range of therapeutic areas, with a focus on infectious diseases, pain management, and ophthalmology. The company boasts a sizable workforce and has a global reach, catering to markets across the world. They are recognized for their commitment to quality, utilizing high-grade chemicals and advanced machinery for production. The company emphasizes its track record in providing quality pharmaceutical products, underscoring its experience in the industry.

Manufacturer usually replies in 5 days

Want to see all 51 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Hyoscine butylbromide

Hyoscine butylbromide, also called scopolamine butylbromide is a medication used in the treatment of Crampy abdominal pain, bladder & esophageal spasms & renal colic. It especially eases the bloating and the spasm-type pain associated with irritable bowel syndrome and diverticular disease. Its actions relax muscles in gastrointestinal and urinary systems. Hyoscine butylbromide also improves respiratory secretions at the end of life. It is also effective in decreasing the duration of the first stage of labor, while not being associated with any obvious adverse outcomes in mother or newborn. HB improves the quality of pictures during abdominal or pelvic MRI or CT. It can also help bladder cramps and period pain. Its medicine form is manufactured from Hyoscine, which occurs naturally in the plant deadly nightshade. Hyoscine butylbromide is sold under the brand name Buscopan among others. Hyoscine butylbromide has not received approved for sales in the United States, but a similar compound, Methscopolamine is used instead. In Europe, the Manufacturer and Licence Holder is Istituto De Angeli S.r.I, Loc. Prulli in Italy and procured from within the EU. The Licence Holder is LTT Pharma Limited from the UK. Forms and Dosage Hyoscine butylbromide is taken orally or given as an injection into a muscle, or into a vein, as a 20 mg in 1 ml ampoule for Intra Muscular or slow Intra Venous injection. In the treatment of MR enterography, the standard prescribed dose is 0.3 mg/kg IV with a maximum dose capped at 20 mg. in the treatment of Acute spasms, the oral medicine for children in the age group of 6-12 yrs old is 10 mg/dose and for 12-18 yrs old: 20 mg/dose. As an injection for either the muscle or nerves, the recommended dosage for children age 2-6 yrs old is 5 mg per dose with max capped at 15 mg per day. For children aged 6-12 years old it is 5-10 mg per dose with max capped at 30 mg per day and for teenagers, in the age group of 12-18 yrs old, the prescribed dose is 20 mg per dose, with max capped at 80 mg/day. For Adults, the standard recommended dose is 10-20 mg per dose up to 3-5 times a day with the maximum capped at 100 mg per day.

The cost of Hyoscine butylbromide

In the developing countries in India, a 2 weeks supply of tablet costs the consumer as low as USD2.3, whereas the injection cost USD1.5. in Australia, 5 ampoules of 20 mg injections cost AUD23.

How does Hyoscine butylbromide work?

Hyoscine butylbromide quaternary ammonium compound as well as a semisynthetic derivative of Scopolamine. As an Antimuscarinic, it binds to muscarinic acetylcholine receptors, blocking their effect. The attachment of the butyl-bromide moiety minimizes undesirable central nervous system side effects associated with scopolamine/Hyoscine, thereby effectively preventing the movement of this drug across the blood-brain barrier. It decreases the stimulation in smooth muscle contractions and the production of respiratory secretions.

Finding Hyoscine butylbromide Manufacturers and Suppliers:

The process of finding trusted Hyoscine butylbromide manufacturers and Hyoscine butylbromide suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Hyoscine butylbromide. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible